Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of aminolevulinic acid during
surgery in treating patients with malignant brain tumors. Aminolevulinic acid becomes active
when it is exposed to a certain kind of light and may help doctors find and remove tumor
cells during surgery